Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age55+
SponsorPeking University People's Hospital
About this trial
This comprehensive, multidimensional evaluation assesses patient-related factors, disease-related factors, donor-related factors, and treatment-related factors. The study aims to identify potential risk factors influencing transplant outcomes in elderly patients and enhance the outcomes of allo-HSCT.
Eligibility criteria
Qualifiers
(a)Age ≥55 years.
(b)Hematologic disorders with established indications for transplantation, including malignant and non-malignant hematologic diseases. (c)Willingness to provide informed consent.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Geriatric Assessment
Treatment groups
176 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov